Ferrer, Lanileah G.
HRN: 24-53-48 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/31/2024
CEFUROXIME 1.5GM (VIAL)
03/31/2024
04/01/2024
IV
1.5gms
Q8hrs
UTI
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes